Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- Acute toxicity
研究概览
简要总结
Motive:
In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from lung cancer patients.
Goal:
To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.
A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with NSCLC or SCLC-LD or thymoma or lung metastases (treated with stereotactic radiotherapy)
- •Patients receiving radiotherapy dose > 40 Gy
排除标准
- •Failure to comply with any of the inclusion criteria
结局指标
主要结局
Acute toxicity
时间窗: Highest during and within 2 weeks after last day of radiation therapy
esophagitis (Common Terminology Criteria for Adverse Events, version 4.0)
Late toxicity
时间窗: Highest within one year after last day of radiation therapy
esophagitis (Common Terminology Criteria for Adverse Events, version 4.0); pneumonitis (Common Terminology Criteria for Adverse Events, version 4.0)
次要结局
- Loco-regional tumor control(at 3 years after first day of radiation therapy)
- Overall survival(at 5 years after first day of radiation therapy)